RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
1233. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival
after acute myocardial infarction in patients with end-stage
renal disease: Results from the Cooperative Cardiovascular
Project. Am J Kidney Dis 35: 1044–1051, 2000.
1234. Aronow WS, Ahn C, Mercando AD, Epstein S: Prevalence of
coronary artery disease, complex ventricular arrhythmias,
and silent myocardial ischemia and incidence of new coronary
events in older persons with chronic renal insufficiency
and with normal renal function. Am J Cardiol 86:1142-
1143,2000.
1235. Wizerman V, Kaufmann J,Kramer W. Effect of erythropoietin
on ischemia tolerance in anemic hemodialysisi patients with
confirmed coronary artery disease. Nephron 62:161-165,
1992.
1236. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis
patients in the United States after coronary angioplasty,
coronary artery stenting and coronary artery bypass surgery
and impact of diabetes. Circulation 106:2207-2211, 2002.
1237. Herzog CA, Ma JZ, Collins AJ. Survival of dialysis patients in
the United States after percutaneous versus surgical coronary
revascularization: Is there a clear choice? Circulation 106
(suppl II): II-492 (abstract), 2002.
1238. Marso S, Gimple LW, Philbrick JT, Dimarco JP. Effectiveness
of percutaneous coronary interventions to prevent recurrent
coronary events inpatients on chronic hemodialysis. Am J
Cardiol 82:378-380, 1998.
1239. Sanai T, Kimura G, Inenaga T, Nonogi H, Haze K, Omae T.
Efficacy of percutaneous transluminal coronary angioplasty
for patients on hemodialysis: comparison with those not on
dialysis. Am J Nephrol 19:38-44, 1999.
1240. Le Feuvre C, Dambrin G, Helft G, Tabet S, Beygui F,
Legendre C y cols. Comparison of clinical outcome following
coronary stenting or balloon angioplasty in dialysis
versus non-dialysis patients. Am J Coll Cardiol 85:1365-
1368, 2000.
1241. Koyanagi T, Nishida H, Kitamura M, Endo M, Koyanagi H,
Kawaguchi M, y cols. Comparison of clinical outcomes of
coronary artery bypass grafting and percutaneous transluminal
coronary angioplasty in renal dialysis patients. Ann
Thorac Surg 61:1793-1796, 1996.
1242. Morice M,Serruys P, Constantini C, Wuelfert E, Wijns W,
Fajadet J y cols. Two-year follow-up of the RAVEL study: A
randomized study with the sirolimus-eluting Bx velocity
stent in the treatment of patients with the-novo native coronary
artery lesions (abstract). J Am Coll Cardiol 41 (suppl A):
32A, 2002.
1243. Gruberg L, Waksman R, Ajani AE, Kim HS, White RL, Pinnow
E y cols. The effect of intracoronary radiation for the treatment
of recurrent in stent restenosis in patients with chronic
renal failure. J Am Coll Cardiol 38:1049-1053, 2001.
1244. Herzog CA, Ma JZ, Collins AJ: Long-term outcome of dialysis
patients in the United States with coronary revascularization
procedures. Kidney Int 56:324-332, 1999.
1245. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl
JA. A comparison of coronary angioplasty and coronary
artery bypass grafting outcomes in chronic dialysis patients.
Am J Kidney Dis 25:281-290, 1995.
1246. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft
FC. Electrom beam computed tomography in the evaluation
of cardiac calcification in chronic dialysis patients. Am J
Kidney Dis 27:394-401, 1996.
1247. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider
D y cols. Coronary artery calcification in young adults with
end-stage renal disease who are undergoing dialysis. N Engl
J Med 342: 1478-1483, 2000.
1248. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM.
Arterial calcifications, arterial stiffness and cardiovascular
risk in end-stage renal disease. Hypertension 38:938-942,
2001.
1249. Hujairi NMA, Afzali B, Goldsmith DJA. Cardiac calcification
in renal patients: What we do and don’t know. Am J Kidney
Dis 2: 234-243, 2004.
1250. Proudfoot D, Shanahan CM. Biology of calcification in vascular
cells: intima versus media. Herz 26:245-51, 2001.
1251. Shioi A, Taniweki H, Hono S,Okuno Y, Koyama H, Mori K y
cols. Monckeberg`s medial sclerosis and inorganic phosphate
in uremia. Am J Kidney Dis 38(supl 1): S47-S49, 2001.
1252. Lanzer P. Monckeberg media calcinosis. Z Kardiol 87:586-
593, 1998.
1253. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening
and vascular calcifications in end-stage renal disease.
Nephrol Dial Transplant 15:1014-021, 2000.
1254. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke
SK y cols. Cardiac calcification in adult hemodialysis
patients. A link between end-stage renal disease and cardiovascular
disease? J Am Coll Cardiol 39:695-701, 2002.
1255. Blacher J, Safar ME, Guerin AP, Pannier B, Marchais SJ,
London GM Aortic pulse wave velocity index and mortality
in end-stage renal disease. Kidney Int 63:1852-1860, 2003.
1256. Rajamannan NM, Subramaniam M, Rickard D, Stock SR,
Donovan J, Springett M y cols. Human aortic valve calcification
is associated with an osteoblast phenotype. Circulation
107:2181-2184, 2003.
1257. Mohler ER III, Adam LP, McClelland P, Graham L, Hathaway
DR. Detection of osteopontin in calcified human aortic valves.
Arterioscler Thromb Vasc Biol 17:547-552, 1997.
1258. Ahmed S, O’Neill KD, Hood AF, Evan AP, Moe SM.
Calciphylaxis is associated with hyperphosphatemia and
increased osteopontin expression by vascular smooth muscle
cells. Am J Kidney Dis 37:1267-1276, 2001.
1259. Moe SM, O’Neill KD, Duan D, Ahmed S, Chen NX, Leapman
SB y cols. Medial artery calcification in ESRD patients is
associated with deposition of bone matrix proteins. Kidney
Int 61:638-647, 2002.
1260. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K
y cols. Phosphate regulation of vascular smooth muscle cell
calcification. Circ Res 87: E10-E17, 2000.
1261. Sattler AM, Schoppet M, Schaefer JR, Hofbauer LC.Novel
aspects on RANK ligand and osteoprotegerin in osteoporosis
and vascular disease. Calcif Tissue Int 74:103-106, 2004.
1262. Cozzolino M, Dusso AS, Slatoolsky E. Role of calcium-phosphate
product and bone associated proteins on vascular calcification
in renal failure. J Am Soc Nephrol 12:2511-2516,
2001.
1263. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M,
Floege J, y cols. The serum protein alpha 2-Heremans-
Schmid glycoprotein/fetuin-A is a systemically acting inhibitor
of ectopic calcification. J Clin Invest 112:357-366,
2003.
1264. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE,
Mahnken AH, Bohm R y cols. Association of low fetuin-A
(AHSG) concentrations in serum with cardiovascular morta-
225